eGFR Calculation Example

CKD-EPI 2021 Equation:

\[ eGFR = 142 \times \min(Scr/\kappa, 1)^\alpha \times \max(Scr/\kappa, 1)^{-1.200} \times 0.9938^{Age} \times (1.012 \text{ if female}) \]

Estimated GFR (eGFR):

Unit Converter ▲

Unit Converter ▼

From:	To:

1. What is the CKD-EPI 2021 Equation?

The CKD-EPI 2021 equation is an updated version that estimates glomerular filtration rate (GFR) from serum creatinine, age, and sex. This refined equation provides improved accuracy in assessing kidney function across different populations.

2. How Does the Calculator Work?

The calculator uses the CKD-EPI 2021 equation:

\[ eGFR = 142 \times \min(Scr/\kappa, 1)^\alpha \times \max(Scr/\kappa, 1)^{-1.200} \times 0.9938^{Age} \times (1.012 \text{ if female}) \]

Where:

\( Scr \) — Serum creatinine (mg/dL)
\( \kappa \) — 0.7 (female) or 0.9 (male)
\( \alpha \) — -0.241 (female) or -0.302 (male)
\( Age \) — Age in years
1.012 — Female multiplier

Explanation: This updated equation incorporates refined coefficients based on larger and more diverse population studies, providing better precision in eGFR estimation.

3. Importance of eGFR Calculation

Details: Accurate GFR estimation is essential for early detection of chronic kidney disease, monitoring disease progression, and making informed clinical decisions regarding treatment and medication adjustments.

4. Using the Calculator

Tips: Enter serum creatinine in mg/dL, age in years, and select gender. Ensure all values are valid (creatinine > 0, age between 1-120 years) for accurate results.

5. Frequently Asked Questions (FAQ)

Q1: What's new in the CKD-EPI 2021 equation?
A: The 2021 version features updated coefficients (142, -1.200, 0.9938) and refined gender adjustments based on more comprehensive population data.

Q2: How does this compare to the original CKD-EPI?
A: The 2021 equation provides improved calibration and better performance across different age groups and ethnic populations.

Q3: What are the clinical applications of this equation?
A: Used for CKD screening, staging, monitoring disease progression, and guiding decisions about nephrology referral and medication dosing.

Q4: Are there population limitations?
A: While improved, caution is still advised in extremes of age, pregnancy, severe malnutrition, and rapidly changing kidney function.

Q5: When should this equation not be used?
A: Not recommended for patients with amputations, muscle wasting diseases, or when using medications that significantly affect creatinine production.